The impact of 2 weeks wait referral on survival of head and neck cancer patients.
Aleix RoviraBeth RussellPriyanka TrivediOnaiho OjoRichard OakleyEdie ByrneAvisha DaryananiMieke Van HemelrijckRicard SimoPublished in: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2023)
The 2 weeks wait head and neck cancer pathway did not offer a survival advantage. Targeting the delay in referral as well as delay in treatment to prevent late-stage cancer presentation is paramount. Fulfilment of cancer time targets do not translate into better outcomes and should not be prioritised to clinical judgement.
Keyphrases
- papillary thyroid
- end stage renal disease
- primary care
- squamous cell
- ejection fraction
- chronic kidney disease
- newly diagnosed
- peritoneal dialysis
- prognostic factors
- free survival
- type diabetes
- gestational age
- metabolic syndrome
- case report
- cancer therapy
- skeletal muscle
- drug delivery
- combination therapy
- smoking cessation
- preterm birth
- replacement therapy